Aspirin use best for those with high coronary calcium, low risk of bleeding
On Oct. 28, 2020, University of Texas (UT) Southwestern scientists reported that an X-ray test commonly used to…
Public health experts at DSHS and UTHealth collaborated on large COVID-19 serological testing assessment
On Oct. 19, 2020, the University of Texas Health Science Center at Houston (UTHealth) announced a partnership with…
Americaﾒs Top Young Scientist of 2020: 14-year-old researched spike protein of SARS-CoV-2 virus
On Oct. 14, 2020, 3M and Discovery Education anounced they had named 14-year-old Anika Chebrolu from Frisco, Texas,…
Vaxess Technologies to develop Coronavirus + Influenza Combo Patch Vaccine in Partnership with Medigen
On Sept. 15, 2020, Vaxess Technologies and Medigen Vaccine Biologics (MBV) announced a partnership to develop a combined…
UTHealth joined NIH trial to test antibodies and other experimental outpatient treatments for COVID-19 pneumonia
On Sept. 15, 2020, the University of Texas Health Science Center at Houston (UTHealth) announced that a study…
NIH augmented large scale study of Alzheimer’s disease biomarkers
On Sept. 10, 2020, the NIH announced that it had added funding for more biomarker measures, including positron…
iBio advanced COVID-19 LicKM-subunit vaccine candidate, IBIO-201
On Sept. 9, 2020, iBio announced that it had selected IBIO-201, its LicKMﾙ-ubunit vaccine, as its leading candidate…
UT Southwestern performed first HIV-positive-to-HIV-positive organ transplant in Texas
On Sept. 2, 2020, UT Southwestern announced that it had performed the first HIV-positive-to-HIV-positive organ transplant in Texas….
Arcadia Biosciences acquired proprietary hemp varieties with acquisition of Industrial Seed Innovations
On Sept. 1, 2020, Arcadia Biosciences announced it had completed the purchase of Oregon-based Industrial Seed Innovations (ISI)…
XBiotech announced COVID-19 candidate therapy
On Aug. 24, 2020, XBiotech announced that the FDA issued an emergency use authorization (EUA) for COVID-19 Convalescent…
Sorrento announced FDA IND filing for COVI-GUARD neutralizing and high potency antibody against SARS-CoV-2
On Aug. 19, 2020, Sorrento announced that it had filed an investigational new drug application (IND) for COVI-GUARD…
UT Southwestern announced open enrollment for at-home COLCORONA clinical trial
On Aug. 19, 2020, researchers at UT Southwestern Medical Center and Texas Health Resources announced what is expected…
XBiotech announced COVID-19 candidate therapy
On Aug. 17, 2020, XBiotech announced that it had identified True Human antibodies that could potentially be used…
Novavax and UK Government announced collaboration and purchase agreement for Novavax’ COVID-19 vaccine candidate
On Aug. 14, 2020, Novavax announced it had signed a Heads of Terms (Term Sheet) with the Government…
NIH-Moderna investigational COVID-19 vaccine showed promise in mouse studies
On Aug. 5, 2020, the National Institute of Allergy and Infectious Diseases (NIAID) announced that the investigational vaccine…
Texas A&M College Station Bio-Manufacturing Center to produce COVID-19 vaccines
On Jul. 27, 2020, FUJIFILM Diosynth Biotechnologies (FDB) and Texas A&M announced they mass will produce vaccines as…
Luminex received FDA Emergency Use Authorization for COVID-19 antibody test
On Jul. 20, 2020, Luminex announced the FDA had issued an Emergency Use Authorization for the company’s xMAPﾮ…
Phase II human trial of ViralClear’s anti-viral for SARS-CoV-2 Coronavirus launched at 4 key trial sites
On Jul. 13, 2020, BioSig Technologies and its subsidiary, ViralClear Pharma announced the enrollment of adult patients for…
UT Southwestern, Texas Health launched collaborative study to better understand COVID prevalence in DFW
On Jul. 10, 2020, researchers at UT Southwestern Medical Center and Texas Health Resources announced that they will…
Texas A&M, MD Anderson Scientists tested inhaled therapeutic to protect against COVID-19
On Jul. 8, 2020, scientists from Texas A&M University, biopharmaceutical company Pulmotect and MD Anderson Cancer Center announced…
Luminex submitted Emergency Use Authorization request to FDA for COVID-19 antibody test
On Jun. 29, 2020, Luminex announced that the company had submitted an Emergency Use Authorization request to the…
Texas A&M researchers testing COVID-19 vaccine candidates for iBio
On Jun. 24, 2020, a team of scientists at Texas A&M University announced it is working with iBio…
Taconic Biosciences announced distribution of critical COVID-19 mouse model
On Jun. 22, 2020, Taconic Biosciences announced an exclusive agreement with the University of Texas Medical Branch at…
ViralClear opened enrollment with first patient dosing in phase II human trial of anti-viral MMPD oral solution for treatment of COVID-19
On Jun. 17, 2020, BioSig Technologies, and its subsidiary, ViralClear, announced that it had commenced patient enrollment with…
ViralClear added St David’s HealthCare to phase II trial for broad-spectrum oral anti-viral COVID-19 candidate
On Jun. 5, 2020, BioSig Technologies and its subsidiary, ViralClear Pharma, announced it had expanded its patient enrollment…
Tonix Pharma announced FUJIFILM Diosynth Biotechnologies to be nanufacturing partner for COVID-19 vaccine candidate TNX-1800
On Jun. 1, 2020, Tonix Pharmaceuticals announced an agreement whereby FUJIFILM Diosynth Biotechnologies will provide contract manufacturing and…
INOVIO COVID-19 DNA vaccine INO-4800 demonstrated robust neutralizing antibody and T cell immune responses in preclinical models
On May 20, 2020, INOVIO announced the publication of the preclinical study data for IN0-4800, its COVID-19 DNA…
Llama antibody engineered to block Coronavirus
On May 19, 2020, the NIH rported that researchers from the University of Texas, in collaboration with a…
ViralClear published F1000 research in vitro data demonstrating synergy between merimepodib and remdesivir against SARS-CoV-2
On May 14, 2020, BioSig Technologies announced that an article titled, “The IMPDH inhibitor merimepodib provided in combination…
Rice University COVID-19 research fund backed six new initiatives
On May 8, 2020, the Rice University COVID-19 Research Fund Oversight and Review Committee announced it had funded…